Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -137.08%-8.81M | -97.60%1.64M | 106.14%23.76M | 259.99%68.33M | -79.92%-387.17M | 7.35%-42.71M | -223.54%-215.2M | -65.36%-46.09M | 69.56%-66.51M | 71.04%-27.87M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -32,600.00%-327K | ---- | 91.67%-1K | ---- | 7.69%-12K | -233.33%-10K | 95.67%-13K | 98.98%-3K | 98.42%-300K | 98.42%-293K |
| Dividend (income)- adjustment | 86.60%-164K | -33.33%-164K | -1,510.53%-1.22M | ---123K | 96.60%-76K | ---- | -48.64%-2.23M | ---- | 55.19%-1.5M | 80.23%-187K |
| Attributable subsidiary (profit) loss | -84.80%38K | -23.17%126K | -2.34%250K | 28.13%164K | 26.11%256K | 60.00%128K | -0.49%203K | -1.23%80K | 397.56%204K | 1,112.50%81K |
| Impairment and provisions: | 45.30%-3.68M | ---- | -155.96%-6.72M | ---1M | 2,995.88%12.01M | ---- | 103.26%388K | ---- | -117.81%-11.88M | -156.43%-6.38M |
| -Other impairments and provisions | 45.30%-3.68M | ---- | -155.96%-6.72M | ---1M | 2,995.88%12.01M | ---- | 103.26%388K | ---- | -117.81%-11.88M | -156.43%-6.38M |
| Revaluation surplus: | 120.28%4.98M | 98.42%-1.14M | -106.81%-24.54M | -306.08%-72.08M | 79.72%360.26M | -7.54%34.98M | 245.85%200.46M | 0.80%37.83M | -61.09%57.96M | -57.48%37.53M |
| -Other fair value changes | 120.28%4.98M | 98.42%-1.14M | -106.81%-24.54M | -306.08%-72.08M | 79.72%360.26M | -7.54%34.98M | 245.85%200.46M | 0.80%37.83M | -61.09%57.96M | -57.48%37.53M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 104.93%255K | --255K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --255K | --255K |
| Depreciation and amortization: | ---- | ---- | ---- | ---- | -66.48%244K | ---- | -62.45%728K | -71.87%344K | -9.56%1.94M | 23.79%1.22M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -71.87%344K | ---- | 23.79%1.22M |
| Financial expense | -4.82%849K | -4.42%433K | 17.83%892K | 25.48%453K | 1.61%757K | -5.00%361K | -56.15%745K | -66.87%380K | -49.36%1.7M | -31.56%1.15M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---26K | ---- |
| Operating profit before the change of operating capital | 6.29%-7.11M | 121.04%897K | 44.73%-7.59M | 41.20%-4.26M | 7.97%-13.73M | 2.85%-7.25M | 17.88%-14.92M | -235.74%-7.46M | 26.67%-18.17M | 140.76%5.5M |
| Change of operating capital | ||||||||||
| Accounts payable increase (decrease) | -238.66%-972K | -112.43%-421K | 115.46%701K | 236.35%3.39M | -690.07%-4.54M | -86.35%1.01M | -106.09%-574K | -10.36%7.38M | 56.92%9.42M | 27.99%8.23M |
| prepayments (increase)decrease | -197.48%-425K | 2,161.43%33.42M | 119.72%436K | 104.63%1.48M | -20,200.00%-2.21M | -980.79%-31.92M | -99.95%11K | 51.19%3.62M | -85.22%20.44M | -98.22%2.4M |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 67.06%-71.26M | 39.61%-71.26M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | --3.92M | --1.32M | ---- | ---- | -55.60%47.48M | --43.43M |
| Cash from business operations | -31.88%-8.51M | 5,531.23%33.9M | 61.02%-6.45M | 101.63%602K | -6.92%-16.55M | -1,141.83%-36.84M | -28.15%-15.48M | 130.20%3.54M | -218.91%-12.08M | -219.74%-11.71M |
| Other taxs | ---- | ---- | ---62K | ---- | ---- | ---- | ---- | ---- | ---132K | ---- |
| Dividend received - operating | -84.72%164K | -89.43%13K | 1,311.84%1.07M | --123K | -96.60%76K | ---- | -42.86%2.23M | ---- | -66.23%3.91M | 53.28%1.45M |
| Interest received - operating | 32,600.00%327K | ---- | -91.67%1K | ---- | -7.69%12K | 233.33%10K | -95.67%13K | -98.98%3K | -97.72%300K | 14.90%293K |
| Net cash from operations | -47.39%-8.02M | 4,577.66%33.91M | 66.96%-5.44M | 101.97%725K | -24.40%-16.47M | -1,140.66%-36.83M | -65.38%-13.24M | 135.51%3.54M | -122.93%-8M | -190.76%-9.97M |
| Cash flow from investment activities | ||||||||||
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | 187,600.00%30M | ---- | ---16K | ---16K |
| Recovery of cash from investments | --74.28M | --149K | ---- | ---- | -41.89%10.67M | ---- | --18.37M | ---- | ---- | ---- |
| Cash on investment | 414.64%32.54M | 7,188.61%5.6M | 120.96%6.32M | ---79K | ---30.17M | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 1,589.47%106.83M | 7,377.22%5.75M | 132.43%6.32M | ---79K | -140.31%-19.5M | ---- | 302,381.25%48.37M | ---- | 83.16%-16K | ---16K |
| Net cash before financing | 11,089.92%98.81M | 6,039.63%39.66M | 102.46%883K | 101.75%646K | -202.37%-35.96M | -1,140.66%-36.83M | 538.08%35.13M | 135.46%3.54M | -123.04%-8.02M | -190.91%-9.98M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---52.98M | ---32.99M |
| Interest paid - financing | 4.82%-849K | 4.42%-433K | -17.83%-892K | -25.48%-453K | -1.61%-757K | 5.00%-361K | 56.15%-745K | 66.87%-380K | 49.36%-1.7M | 31.56%-1.15M |
| Net cash from financing operations | 0.14%-1.45M | 0.00%-729K | -4.16%-1.45M | -1.67%-729K | 2.17%-1.4M | -0.14%-717K | 97.46%-1.43M | 97.96%-716K | -1,063.45%-56.09M | -1,311.90%-35.11M |
| Effect of rate | -5,152.94%-893K | ---649K | 98.96%-17K | ---- | -1,006.76%-1.64M | -327.69%-1.29M | -102.82%-148K | 104.62%567K | 538.66%5.24M | -1,588.11%-12.26M |
| Net Cash | 17,180.00%97.36M | 47,007.23%38.93M | 98.47%-570K | 99.78%-83K | -210.84%-37.36M | -1,430.00%-37.55M | 152.57%33.7M | 106.26%2.82M | -313.82%-64.11M | -631.03%-45.1M |
| Begining period cash | -96.86%19K | -96.86%19K | -98.47%606K | -98.47%606K | 555.20%39.6M | 555.20%39.6M | -90.69%6.04M | -90.69%6.04M | 79.69%64.91M | 79.69%64.91M |
| Cash at the end | 507,700.00%96.48M | 7,223.71%38.3M | -96.86%19K | -31.45%523K | -98.47%606K | -91.91%763K | 555.20%39.6M | 24.89%9.43M | -90.69%6.04M | -83.38%7.55M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.55M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.55M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Yung Shing (Hong Kong) Certified Public Accountants Limited | -- | Yung Shing (Hong Kong) Certified Public Accountants Limited | -- | Yung Shing (Hong Kong) Certified Public Accountants Limited | -- | Moore Stephens CPA Limited | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.